334 related articles for article (PubMed ID: 37417238)
1. Management of Stroke in Patients With Chronic Liver Disease: A Practical Review.
Parikh NS; Basu E; Hwang MJ; Rosenblatt R; VanWagner LB; Lim HI; Murthy SB; Kamel H
Stroke; 2023 Sep; 54(9):2461-2471. PubMed ID: 37417238
[TBL] [Abstract][Full Text] [Related]
2. Bleeding Risk and Management in Interventional Procedures in Chronic Liver Disease.
DeAngelis GA; Khot R; Haskal ZJ; Maitland HS; Northup PG; Shah NL; Caldwell SH
J Vasc Interv Radiol; 2016 Nov; 27(11):1665-1674. PubMed ID: 27595469
[TBL] [Abstract][Full Text] [Related]
3. Coagulation abnormalities in patients with chronic liver disease in Pakistan.
Siddiqui SA; Ahmed M; Ghani MH; Memon MA; Mustafa G; Ghori MA
J Pak Med Assoc; 2011 Apr; 61(4):363-7. PubMed ID: 21465974
[TBL] [Abstract][Full Text] [Related]
4. Clotting abnormalities in chronic liver disease.
Violi F; Ferro D; Quintarelli C; Saliola M; Cordova C; Balsano F
Dig Dis; 1992; 10(3):162-72. PubMed ID: 1611712
[TBL] [Abstract][Full Text] [Related]
5. Rebalanced hemostasis in liver disease: a misunderstood coagulopathy.
Roberts LN
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):485-491. PubMed ID: 34889414
[TBL] [Abstract][Full Text] [Related]
6. Trends, management and outcomes of acute myocardial infarction in chronic liver disease.
Matetic A; Contractor T; Mohamed MO; Bhardwaj R; Aneja A; Myint PK; Rakoski MO; Zieroth S; Paul TK; Mamas MA
Int J Clin Pract; 2021 Apr; 75(4):e13841. PubMed ID: 33220158
[TBL] [Abstract][Full Text] [Related]
7. Prothrombinex®-VF in chronic liver disease: Friend or foe?
Latona A; Hill K; Connelly A; Stuart K; Wood P
Emerg Med Australas; 2023 Feb; 35(1):89-96. PubMed ID: 35993256
[TBL] [Abstract][Full Text] [Related]
8. Avatrombopag for the treatment of thrombocytopenia in patients with chronic liver disease.
Xu H; Cai R
Expert Rev Clin Pharmacol; 2019 Sep; 12(9):859-865. PubMed ID: 31352834
[No Abstract] [Full Text] [Related]
9. Review article: a treatment algorithm for patients with chronic liver disease and severe thrombocytopenia undergoing elective medical procedures in the United States.
Dieterich DT; Bernstein D; Flamm S; Pockros PJ; Reau N
Aliment Pharmacol Ther; 2020 Oct; 52(8):1311-1322. PubMed ID: 32813292
[TBL] [Abstract][Full Text] [Related]
10. Management of Thrombocytopenia in Patients with Chronic Liver Disease.
Saab S; Brown RS
Dig Dis Sci; 2019 Oct; 64(10):2757-2768. PubMed ID: 31011942
[TBL] [Abstract][Full Text] [Related]
11. Treatment Options for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing a Scheduled Procedure.
Saab S; Bernstein D; Hassanein T; Kugelmas M; Kwo P
J Clin Gastroenterol; 2020 Jul; 54(6):503-511. PubMed ID: 32195771
[TBL] [Abstract][Full Text] [Related]
12. Hepatic coagulopathy-intricacies and challenges; a cross-sectional descriptive study of 110 patients from a superspecialty institute in North India with review of literature.
Kar R; Kar SS; Sarin SK
Blood Coagul Fibrinolysis; 2013 Mar; 24(2):175-80. PubMed ID: 23358200
[TBL] [Abstract][Full Text] [Related]
13. Introduction: thrombocytopenia in chronic liver disease -- treatment implications and novel approaches.
Afdhal NH; Esteban R
Aliment Pharmacol Ther; 2007 Nov; 26 Suppl 1():1-4. PubMed ID: 17958513
[TBL] [Abstract][Full Text] [Related]
14. Assessing in-hospital cardiovascular, thrombotic and bleeding outcomes in patients with chronic liver disease undergoing left ventricular assist device implantation.
Grant JK; Ebner B; Vincent L; Maning J; Olorunfemi O; Olarte NI; Colombo R; Munagala M; Chaparro S
Thromb Res; 2021 Jun; 202():184-190. PubMed ID: 33892219
[TBL] [Abstract][Full Text] [Related]
15. Current Advance in Thrombopoietin Receptor Agonists in the Management of Thrombocytopenia Associated With Chronic Liver Disease: Focus on Avatrombopag.
Abdela J
Clin Med Insights Blood Disord; 2019; 12():1179545X19875105. PubMed ID: 31673229
[TBL] [Abstract][Full Text] [Related]
16. Chronic liver disease, thrombocytopenia and procedural bleeding risk; are novel thrombopoietin mimetics the solution?
Olson SR; Koprowski S; Hum J; McCarty OJT; DeLoughery TG; Shatzel JJ
Platelets; 2019; 30(6):796-798. PubMed ID: 30422039
[TBL] [Abstract][Full Text] [Related]
17. The effect of chronic liver disease on venous thromboembolism among medically managed patients in Singapore General Hospital.
Yang Y; Zhang XZ; Ng HS; Fong JC; Lee LH
Thromb Res; 2015 Sep; 136(3):548-51. PubMed ID: 26164397
[TBL] [Abstract][Full Text] [Related]
18. Avatrombopag: A Review in Thrombocytopenia.
Markham A
Drugs; 2021 Nov; 81(16):1905-1913. PubMed ID: 34709601
[TBL] [Abstract][Full Text] [Related]
19. Contemporary Trends in Hospitalizations for Comorbid Chronic Liver Disease and Substance Use Disorders.
Desai AP; Greene M; Nephew LD; Orman ES; Ghabril M; Chalasani N; Menachemi N
Clin Transl Gastroenterol; 2021 Jun; 12(6):e00372. PubMed ID: 34142663
[TBL] [Abstract][Full Text] [Related]
20. [Management strategies for chronic liver disease-related thrombocytopenia].
Qian JD; Yao TT; Wang Y; Wang GQ
Zhonghua Gan Zang Bing Za Zhi; 2021 Sep; 29(9):896-899. PubMed ID: 34638215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
